perioperative pain
Conditions
Interventions
Test group:acupoint injection
control group:no intervention
Sponsors
Xiangyang Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: Patients between the ages of 18 and 75 2:American Association of Anesthesiologists is classified as l to ? 3:undergoing nasal endoscopic surgery under general anesthesia
Exclusion criteria
Exclusion criteria: 1:Patients with Alzheimer's disease schizophrenia or depression; 2: individuals with a history of chronic pain or long-term use of sedatives or analgesics; 3: Chronic patients with hypermagnesemia calcium channel blockers or beta blockers and uncontrolled hypertension 4: History of heart block myocardial infarction or severe coronary heart disease (stenosis degree>80%) in the past 5:History of cerebral infarction and cerebral hemorrhage in the past; 6: Previous severe lung liver and kidney dysfunction and preoperative moderate to severe anemia (Hb<90g/L); 7:Breastfeeding women or pregnant women; 8:Participated in other clinica studies within the past 3 months of enrollment 9:refuse to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraoperative consumption of remifentani;weighted NRS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| intraoperative consumption of propofol;postoperative fatigue;extubation time;the score of QoR-15; | — |
Countries
China
Contacts
Public ContactXingrui Gong
Xiangyang Central Hospital
Outcome results
None listed